(Q86525641)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

title

FGF-23, vascular calcification, and cardiovascular diseases in chronic hemodialysis patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

main subject

vascular calcification

1 reference

Diana Moldovan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ioan Moldovan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Crina Rusu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ina Kacso

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Ioan Mihai Patiu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

Mirela Gherman-Caprioara

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

publication date

3 April 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

International Urology and Nephrology

27 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

volume

46

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

page(s)

121-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

Serum fibroblast growth factor-23 levels predict the future refractory hyperparathyroidism in dialysis patients.

27 February 2020

cites work

1 reference

12 December 2020

Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease

1 reference

12 December 2020

Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences

1 reference

12 December 2020

Plasma levels of fibroblast growth factor-23 and mineral metabolism in diabetic and non-diabetic patients on chronic hemodialysis

1 reference

12 December 2020

Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population

1 reference

12 December 2020

Fibroblast growth factor 23: a possible cause of left ventricular hypertrophy in hemodialysis patients

1 reference

12 December 2020

Relationship between circulating FGF23 and total body atherosclerosis in the community

1 reference

12 December 2020

FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality

1 reference

12 December 2020

FGF-23 and osteoprotegerin are independently associated with myocardial damage in chronic kidney disease stages 3 and 4. Another link between chronic kidney disease-mineral bone disorder and the heart

1 reference

12 December 2020

Arterial intima and media calcification: distinct entities with different pathogenesis or all the same?

1 reference

12 December 2020

High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.

1 reference

12 December 2020

Fibroblast growth factor 23: friend or foe in uremia?

1 reference

12 December 2020

The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis

1 reference

12 December 2020

FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment

1 reference

12 December 2020

Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease

1 reference

12 December 2020

Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study

1 reference

12 December 2020

The potential roles of FGF23 and Klotho in the prognosis of renal and cardiovascular diseases

1 reference

12 December 2020

Peripheral artery calcifications evaluated by histology correlate to those detected by CT: relationships with fetuin-A and FGF-23

1 reference

12 December 2020

Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice

1 reference

12 December 2020

Amelioration of the premature ageing-like features of Fgf-23 knockout mice by genetically restoring the systemic actions of FGF-23

1 reference

12 December 2020

Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study

1 reference

12 December 2020

Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease

1 reference

12 December 2020

Impact of fibroblast growth factor 23 on lipids and atherosclerosis in hemodialysis patients

1 reference

12 December 2020

Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients

1 reference

12 December 2020

Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality.

1 reference

12 December 2020

Role of fibroblast growth factor-23 in peripheral vascular calcification in non-diabetic and diabetic hemodialysis patients

1 reference

12 December 2020

Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?

1 reference

12 December 2020

Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis

1 reference

12 December 2020

Serum fibroblast growth factor-23 levels and progression of aortic arch calcification in non-diabetic patients on chronic hemodialysis

1 reference

12 December 2020

Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.

1 reference

12 December 2020

Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients

1 reference

12 December 2020

A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients

1 reference

12 December 2020

The phosphatonin fibroblast growth factor 23 links calcium-phosphate metabolism with left-ventricular dysfunction and atrial fibrillation

1 reference

12 December 2020

Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?

1 reference

12 December 2020

Relation between plasma fibroblast growth factor-23, serum fetuin-A levels and coronary artery calcification evaluated by multislice computed tomography in patients with normal kidney function.

1 reference

12 December 2020

10.1007/S11255-013-0422-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23549862%20AND%20SRC:MED&resulttype=core&format=json

27 February 2020

1 reference